Previously, most of study on developing CRISPR-based DMD treatment performed gene editing of mouse DMD sequences20, which shows variations between species and impedes the evaluation of human-specific sgRNA for translational study. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.